Prenatal opioid exposure and the early life epigenome: results from ECHO

Rose Schrott,Henri Garrison-Desany,Lyndsay Avalos,Carrie V. Breton,Dana M. Dabelea,Karen Derefinko,Anne Dunlop,Fang Fang,Abigail Gaylord,Torie Grant,Marie-France Hivert,Margaret R. Karagas,Anna K. Knight,Barry Lester,Kristen Lyall,Cindy McEvoy,Ruby Nguyen,Grier Page,Alison Paquette,Douglas Ruden,Lyndsey E Shorey-Kendrick,Alicia K. Smith,Eliot Spindel,Heather E. Volk,Christine Ladd-Acosta

DOI: https://doi.org/10.1080/14659891.2024.2356569

2024-05-29

Journal of Substance Use

Abstract:Background Prenatal opioid exposure has been associated with adverse child health outcomes. Changes to the epigenome provide a plausible mechanism through which effects may be elicited. We investigated whether prenatal opioid exposure was associated with locus-specific changes in umbilical cord blood DNA methylation (DNAm) and gestational epigenetic age.

substance abuse